Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...

A Cardiff-based artificial intelligence-driven Techbio company has secured a joint equity investment to accelerate its drug discovery work and create jobs.

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

The session Next-Generation Drug Development Enabled by Automation, Digitalization, and AI/ML is scheduled to take place at Pittcon 2026 in San Antonio, TX, on Monday, March 9, from 8:30 am–10:40 am ...

A new review titled Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and ...

TAIPEI and SAN DIEGO, March 3, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, ...

Clinical Trials suffer due to inherent inefficiencies in manual workflows built on fragmented systems. It's time for a ...

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and other conditions.

AI Foundation Models to Enable Precision ADC Clinical Development and Response Intelligence BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a ...

AI could review data sets to assist clinical scientists ...

Mark Flather and Dr. Fred Brown join to expand adoption of Derisq™ and Operon™, delivering AI-powered risk prediction and portfolio optimization for biotech investors and pharmaceutical ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.